We present the first direct evidence that adverse effects, particularly severe destructive arthritis, can develop in vaccinated hamsters after challenge with Borrelia burgdorferi sensu lato isolates. Hamsters were vaccinated with a whole-cell preparation of Formalin-inactivated B. burgdorferi sensu stricto isolate C-i-li in adjuvant. A severe destructive arthritis was readily evoked in vaccinated hamsters challenged with the homologous B. burgdorferi sensu stricto isolate C-i-li before high levels of protective borreliacidal antibody developed. Once high levels of C-i-11 borreliacidal antibody developed, hamsters were protected from homologous challenge and development of arthritis. Vaccinated Lyme borreliosis is caused by the spirochete Borrelia burgdorfeie sensu lato (3, 5, 19) and is transmitted primarily to human hosts by Ixodes ticks (6, 49, 50) . Its most characteristic clinical feature is an expanding skin lesion, erythema migrans, yet patients with the illness may present with arthritic, cardiac, or neurological symptoms without a skin lesion (46, 47, 53) . The signs and symptoms of the disease change frequently and are often intermittent. If the infection is left untreated, chronic arthritis may develop in weeks or months. Today, Lyme borreliosis has become the most frequently reported tickassociated illness in the United States (8) since it was first consistently reported in the 1970s (48, 51, 52).
Lyme borreliosis is caused by the spirochete Borrelia burgdorfeie sensu lato (3, 5, 19) and is transmitted primarily to human hosts by Ixodes ticks (6, 49, 50) . Its most characteristic clinical feature is an expanding skin lesion, erythema migrans, yet patients with the illness may present with arthritic, cardiac, or neurological symptoms without a skin lesion (46, 47, 53) . The signs and symptoms of the disease change frequently and are often intermittent. If the infection is left untreated, chronic arthritis may develop in weeks or months. Today, Lyme borreliosis has become the most frequently reported tickassociated illness in the United States (8) since it was first consistently reported in the 1970s (48, 51, 52) .
The high level of interest in Lyme borreliosis has facilitated a worldwide effort to develop an effective vaccine against B. burgdorferi sensu lato. The feasibility of vaccination has been demonstrated in dogs (9, 26) , gerbils (33) , hamsters (17, 18, 20) , and mice (12, 13, 43, 44, 54, 55) . Viable (21, 23, 30, 32, 36, 39, 40) and nonviable (9, 17, 18, 20, 22, 26) Lyme borreliosis spirochetes and several of their outer surface proteins, including OspA (12, 13, 34, 35, 37, 38, 43, 44, 54, 55) , OspB (14, 34, 35, 55) , OspC (33) , and the 39-kDa protein (41) , have been shown to induce protective antibodies capable of killing isolates of B. burgdorferi sensu lato in vitro or preventing infection in animals. Other spirochetal components may also be involved. Recently, a whole-cell vaccine for dogs has become available commercially (9, 18, 26) , and field trials involving humans with OspA, as a vaccine are being conducted. Although vaccination studies are progressing, there are impor-tant concerns about the heterogenicity (4, 15, 24, 31, (56) (57) (58) (59) and immunogenicity (10, 54) of nonviable whole spirochetes and subunit components. In addition, the possibility of adverse effects developing from vaccination with or without adjuvants must be considered.
In this study, we present the first direct evidence that an adverse effect, especially severe destructive arthritis, can develop after vaccination against the Lyme borreliosis spirochete. We describe the development of severe destructive arthritis in mature immunocompetent hamsters vaccinated with a wholecell preparation of Formalin-inactivated B. burgdorferi sensu lato in adjuvant after challenge with isolates of the three genomic groups of B. burgdorfer sensu lato.
MATERIALS AND METHODS
Hamsters. Six-to 8-week-old inbred LSH/Ss WSLH hamsters were obtained from our breeding colony located at the Wisconsin State Laboratory of Hygiene. Hamsters weighing 60 to 120 g were housed three per cage at an ambient temperature of 21°C. Food and water were available ad libitum.
Organisms. Low-passage (<10) virulent isolates of the three (20, 22) .
Hamster sera. Sera were obtained from hamsters vaccinated with Formalin-inactivated B. burgdorferi sensu stricto isolate C-1-11 or 297 with and without adjuvant at various intervals after vaccination. Concomitantly, sera were obtained from noninfected normal hamsters. Hamsters were anesthetized with ether and bled by intracardiac puncture. The blood was allowed to clot, and serum was separated by centrifugation at 500 x g, pooled, divided into 1-ml aliquots, dispensed into 1.5-ml screw-cap tubes (Sarstedt), and frozen at -20°C until used.
Borreliacidal assay. A previously described procedure (30) was modified and used to determine borreliacidal activity. Sera from vaccinated and nonvaccinated hamsters were heat inactivated at 56°C for 30 min, diluted 1:10 with fresh BSK, and filter sterilized through a 0. (27) . The Recovery of spirochetes from tissues. Twenty-one days after challenge, hamsters were killed by CO2 inhalation. The urinary bladder, spleen, left kidney, and heart were removed aseptically, homogenized through a 5-ml syringe, and inoculated into considered negative. For recovery of B. hermsii, blood was inoculated into 5 ml of BSK supplemented with antibiotics.
Preparation of tissues for histology. The hind legs of all vaccinated and nonvaccinated hamsters were amputated 21 days after challenge at the midfemur, fixed in 10% neutral buffered Formalin, placed in decalcifying solution (Lemer Laboratories, Pittsburgh, Pa.) for 18 h, and stored in 10% Formalin prior to processing. The knees and hind paws were bisected longitudinally, embedded in paraffin, cut into 6-,um sections, placed on glass slides, and stained with hematoxylin and eosin. Hind legs were randomly selected from each group of hamsters for histopathological examination.
Statistics. The plethysmograph values obtained from hamster hind paw measurements were tested by analysis of variance. The Fisher least-significant-difference test (45) was used to examine pairs of means when a significant F ratio indicated reliable mean differences. The alpha level was set at 0.05 before the experiments were started.
RESULTS
Development of borreliacidal antibody in vaccinated hamsters. Two groups of 15 hamsters each were vaccinated with a single dose of a whole-cell preparation of Formalin-inactivated B. burgdorferi sensu stricto isolate C-1-11 in PBS or an aluminum hydroxide gel. Borreliacidal antibody titers were determined at 1, 3, 5, 7, and 9 weeks after vaccination by flow cytometry. One week after vaccination, low levels of borreliacidal antibody were detected in pooled sera from three hamsters vaccinated with the preparations of Formalin-inactivated spirochetes (Fig. 1) . However, hamsters vaccinated with Formalin-inactivated spirochetes in adjuvant had a 2-to 16-fold increase in borreliacidal antibody titer 3 weeks or later after vaccination.
Development of severe destructive arthritis in vaccinated hamsters. Five groups of three hamsters each were vaccinated with Formalin-inactivated B. burgdorferi sensu stricto isolate C-1-11 in aluminum hydroxide gel. At 1, 3, 5, 7, and 9 weeks after vaccination, hamsters were challenged subcutaneously in the hind paws with 106 viable organisms of B. burgdorferi sensu stricto isolate C-1-11. Hamsters challenged 5 weeks or less after vaccination developed severe swelling of the hind paws ( Fig. 2 and 3C ). Swelling was detected 5 days after challenge and increased rapidly, with peak swelling occurring on days 14 to 16 after challenge before gradually decreasing. Spirochetes were also recovered from the urinary bladder, spleen, kidney, and heart of these hamsters after cultivation in BSK for 10 days 0.8- ( Table 1) . By contrast, hamsters challenged 7 and 9 weeks after vaccination failed to develop swelling of the hind paws (Fig. 2) , and their tissues did not grow spirochetes when cultured in BSK (Table 1) . Slight swelling of the hind paws was detected when nonvaccinated hamsters and hamsters inoculated with adjuvant alone were challenged with B. burgdorfen sensu stricto isolate C-1-11 ( Fig. 2 and 3B ). The swelling, however, was significantly less (P < 0.01) and of shorter duration than the swelling in hamsters challenged 1, 3, and 5 weeks after vaccination with Formalin-inactivated spirochetes in adjuvant.
The tissues of these hamsters also grew spirochetes when cultured in BSK for 10 days (Table 1 ). In addition, nonvaccinated hamsters and hamsters vaccinated with BSK failed to develop any swelling of the hind paws ( Fig. 2 and 3A) . (Fig. 3C ).
The synovia of the tibiotarsal and intertarsal joints displayed chronic hypertrophy and hyperplasia characterized by bridging of villi mixed with fibrin (pannuslike), erosion of the articular cartilage, and focal destruction of underlying bone (Fig. 3C) (Fig. 3B) . A cellular inflammatory infiltrate was present, but the joint spaces were free of pannus tissue formation and the development of erosive and destructive arthritis. (Fig. 3B) . Similar histopathological findings were also seen in the hind paws of hamsters infected with B. burgdorferi sensu stricto isolate C-1-11 after vaccination with Formalininactivated B. burgdorferi sensu stricto isolate C-1-11 in PBS or with adjuvant alone (data not shown). Nonvaccinated hamsters inoculated with BSK also failed to develop any significant histological changes (Fig. 3A) . Effects of various adjuvants on development of severe destructive arthritis. Three groups of three hamsters each were challenged subcutaneously in the hind paws with 106 viable organisms of B. burgdorferi sensu stricto isolate C-1-11 5 weeks after vaccination with Formalin-inactivated B. burgdorferi sensu stricto isolate C-1-11 in aluminum hydroxide gel, aluminum hydroxide (Imject alum), or Freund's incomplete adjuvant. All vaccinated hamsters developed severe swelling of the hind paws 5 days after infection (Fig. 4) . The swelling peaked on days 14 to 16 after challenge and gradually decreased. Spirochetes were also recovered from their tissues after cultivation in BSK for 10 days (Table 2) . Although nonvaccinated hamsters challenged with B. burgdorferi sensu stricto isolate C-1-11 developed slight swelling, the severity of swelling was significantly less (P < 0.01) than that measured in vaccinated hamsters and was of shorter duration (Fig. 4) (Table 3) . No swelling of the hind paws was detected in vaccinated hamsters challenged with the homologous isolate, nor were spirochetes isolated from the tissues of these animals. When vaccinated hamsters were challenged with the nonhomologous isolate of B. burgdorferi sensu stricto, B. garinii, or B. afzelii, severe swelling of the hind paws developed and spirochetes were isolated from the tissues of these hamsters even though high levels of isolate-specific borreliacidal antibody were present (Table 3) . Hamsters vaccinated with Formalin-inactivated B. burgdorferi sensu stricto isolate C-1-11 or 297 in adjuvant failed to develop any swelling of the hind paws when challenged with B. hermsii, although spirochetes were isolated from the blood.
DISCUSSION
This is the first documentation that severe destructive arthritis can develop after vaccination against infection with B. burgdorferi sensu lato. Arthritis was readily evoked in vaccinated hamsters challenged with isolates of B. burgdorfeni sensu lato before high levels of protective borreliacidal antibody had developed. Once high levels of isolate (vaccine)-specific borreliacidal antibody developed, hamsters were protected from homologous challenge and development of arthritis. However, vaccinated hamsters still developed severe destructive arthritis when challenged with other isolates of the three genomic groups of B. burgdorferi sensu lato. Our results demonstrate (2) . We showed that vaccination with Formalin-inactivated spirochetes in the absence of adjuvant induced only a weak borreliacidal antibody response. Borreliacidal antibody accurately reflects the level of protective antibody (40) . When Formalin-inactivated spirochetes were incorporated in adjuvant, high levels of borreliacidal antibody developed 7 weeks or more after vaccination. Vaccinated hamsters were protected from homologous challenge. Surprisingly, hamsters vaccinated with spirochetes in adjuvant developed severe destructive arthritis when challenged with the homologous isolate before high levels of borreliacidal antibody were detected. Furthermore, vaccinated hamsters developed severe destructive arthritis when challenged with other isolates of the three genomic groups of B. burgdorferi sensu lato, even when high levels of isolate-specific borreliacidal antibody were present. Our results also showed that development of arthritis was caused by the spirochetes and not by the adjuvants. These findings suggest that vaccines prepared from whole spirochetes should be tested for their ability to induce arthritis or other clinical manifestations of Lyme borreliosis by challenging vaccinated animals with multiple isolates of B. burgdorferi sensu lato before and after the establishment of high levels of protective borreliacidal antibody.
Our results suggest that alternative approaches, besides whole spirochetes, need to be considered for the development of Lyme borreliosis vaccines. One approach would be to use selected proteins or other antigens of B. burgdorferi sensu lato that are known to induce protective borreliacidal antibody. Several B. burgdorferi sensu lato proteins, including OspA (12, 13, 43, 44, 54, 55) , OspB (14, 34, 35, 55) , OspC (33) , and the 39-kDa protein (40) have been shown to induce killing antibody. Although OspA is currently the leading vaccine candidate, it has considerable immunologic (4, 15, 38) and molecular (24, 31, 59) heterogeneity. This may require several OspA proteins for development of a comprehensive vaccine. We have shown that isolates of B. burgdorferi sensu lato can be separated into at least five distinct seroprotective groups (28, 29) . This suggests that combinations of B. burgdorfeni sensu lato protective proteins may be required to provide a comprehensive vaccine for humans and other animals. The ability of these proteins alone or in combination to induce or elicit adverse clinical manifestations is unknown and must be evaluated before their inclusion in a vaccine. Likewise, the immunogenicity of these purified proteins must be determined. An adjuvant may be required for the induction of an adequate protective antibody response and may enhance the potential for adverse effects. Another approach for vaccination would be to use whole spirochetes and eliminate or remove the antigen(s) responsible for the induction of arthritis or other possible autoreactive pathologic responses (1, 16, 25, 42 A third explanation may be that the route of challenge influenced the development of arthritis. We have also evoked arthritis in vaccinated hamsters challenged intradermally and intraperitoneally. However, the onset of arthritis was delayed by approximately 20 days and the swelling of the hind paws was less severe in these animals. The late development of arthritis may not have been observed by other investigators. A fourth explanation is that the hamster is unique. Hamsters may process whole spirochetes in adjuvant differently than other animals. It is important to note that serious adverse reactions in dogs to a commercially available whole-cell vaccine containing an adjuvant have not been reported to date (9, 26) . Likewise, other animals have not developed arthritis despite vaccination with whole spirochetes in adjuvant (17, 18, 20) . Even if other animal models do not develop arthritis after vaccination, the hamster's propensity for development of arthritis may lead to a better understanding of the immune mechanisms responsible for the induction and development of arthritis.
Our results also suggest that humorally mediated responses are not responsible for the development of severe destructive arthritis in hamsters. Arthritis was evoked in the presence and absence of borreliacidal antibody and of antibody used for the serodiagnosis of Lyme disease. Passive transfer of serum from hamsters vaccinated with Formalin-inactivated B. burgdorferi sensu stricto isolate C-1-11 did not induce arthritis when naive syngenic recipient hamsters were challenged with the homologous isolate or other isolates of B. burgdorferi sensu lato, even after daily administration of serum for 7 days (data not shown). Likewise, Fikrig et al. (11) showed that active immunization with OspA did not enhance arthritis but hastened its resolution. These results and those obtained by histopathology suggest that cell-mediated responses are involved. Additional studies are needed to determine whether severe destructive arthritis can be passively transferred with cells or abrogated in vaccinated hamsters by treatment with specific T-lymphocyte reagents.
In summary, severe destructive arthritis developed in vaccinated hamsters. Although vaccinated hamsters failed to de-VOL. 62, 1994 on January 27, 2018 by guest http://iai.asm.org/ Downloaded from velop arthritis when challenged with the homologous isolate during periods when the levels of isolate-specific borreliacidal antibody were high, they developed severe destructive arthritis when challenged before borreliacidal antibody developed or when challenged with different isolates of B. burgdorferi sensu lato. The induction and development of arthritis was not dependent on the isolate of B. burgdorferi sensu lato or the type of adjuvant used. Additional studies are needed to define the antigen(s) responsible for the induction of arthritis and the mechanism(s) involved. These investigations are needed to understand the immune mechanisms responsible for arthritis and for the development of a safe vaccine for prevention of Lyme borreliosis.
